yes $110 mn FCCB leads to around 500+ crs @ Rs/$ equation 47Rs/per$.
Even it will be much more if one goes for reduption before convertibility.
Its a clause......................! I don`t think it will be executed. Wockhardt is quite positive on that frount. Private equity can help to clear this. I don`t expect any negative impact on wockhardt.

Buy for investment....

Wockhardt Ltd expected to report 9550 mn in revenues. EBITDA to be at 245 Crs and PAT likely to be in the range 140-150 Crs.

Revenue break up regionwise.

INDIA - 2400 mn
EUROPE- 4600 mn
US - 1950 mn
ROW - 0600 mn
================
TOTAL - 9550 mn

Operating Profit margines likely to be at 25.5 %. PAT may be impacted by higher interest cost and Depreciation.
Wockhardt will capitalise its R&D expenses to the tune of 25 Crs for this qtr.
I do not expect any negative impact of currency fluctuations.
...

It has nothing to do with Wock hospital IPO.....................

Dear guest. I will post acurate result expectations later.
At present you may go throug this for rough reference.

Revenues wockhardt Q3 expectation
India - 2500+ mn
Europe- 4600 mn
US - 1600 mn
ROW - 1000 mn
----------------
Total - 9700 mn

Operating Profit margine will be at 240+ Cr and PAT at 125+ Cr....

Having removal of cough medicines like Benedryl and many other spurious drugs from market , it will provide an opportinity for other domestic trusted pharma to operate in this line. ZEDEX , a cough syrup will do well in future. There were much dengue cases reported this year. Wock has strong portfolio of drugs for these. Many in-licensed product launch will also generate revenue for wock this quarter.
Apart from these rupee depreciation will bring more revenues from foreign markets. These all will sure help in singnificant increase of revenues , simultaniously in OPM....

Some of the blue chips were over priced........... For ex Reliance fell from 3000+ levels to 1700 levels
Larsen Toubro fell from 4000+ to 2400 levels
Dlf from 1200+ to 500
Reliance energy............?

but wockhardt is rich in value and uder priced......
The market sentiments made it to suffer.

If you are a value investor , please have patience.

Bye
...

Yes cent percent right. Iff one has left with fund........!
I am sure R&D capitalisation process will be over by 2009. Demerger of R&D unit will sure compensate that for 2009. 12-18-24 months will be a rewarding ones.
bye...

FCCB of 11 crore dollar amtg.508 crores[indian rupees]conversion rate at Rs.629.80 due october -09. total debt of Rs.2961 crores. If company goes for BONDS REDEMPTION they will have to pay Rs.650 crores{around 14 crore dollar}.printed in a leading newspaper. IS IT TRUE ?Then what will the consequenses co.will have to face? ...

compare their cash flow statement and gearing ratio with that of Unichem and you\\`d get the answer...yea...wockhardt has too much debt on it!...

Hi LEO THE LION, I also tracking this stock since long. At that time I bought @ 350/0 & sold @ 420/-. I could not gather the reason for going down this stock so much, whether present market condition OR failure of his IPO Wockhardt hospital OR healthcare? Is it proper to enter this stock at present rate? ...

what are the results expectations in this quarter? any idea ?...

Thanks a lot. I think besides sitting tight in this mayhem, long term investors may add more to thier portofolio, if left with investible fund....